Edgewise Therapeutics, Inc. (NASDAQ:EWTX) has 210 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 15,518,492 | 0 | 0.00% | $488,832,498.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 11,831,112 | 7,264,262 | 159.07% | $372,578,164.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,428,437 | 0 | 0.00% | $328,495,766.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 7,365,038 | 823,828 | 12.59% | $231,998,697.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 6,575,940 | 0 | 0.00% | $207,142,110.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 6,472,991 | -157,585 | -2.38% | $203,899,220.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 5,350,000 | 0 | 0.00% | $168,525,000.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,477,942 | 286,749 | 6.84% | $141,055,173.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 4,430,263 | -99,727 | -2.20% | $139,553,285.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 4,423,974 | -34,000 | -0.76% | $139,355,181.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,788,161 | 3,788,161 | 0.00% | $119,327,072.00 |
| Cormorant Asset Management, LP | 31 Mar, 2026 | 3,260,000 | -25,000 | -0.76% | $102,690,000.00 |
| BRAIDWELL LP | 31 Mar, 2026 | 2,347,583 | -2,863,248 | -54.95% | $73,948,865.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,246,028 | -664,853 | -22.84% | $70,749,883.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,789,819 | 43,597 | 2.50% | $56,391,016.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 1,722,169 | 685,999 | 66.21% | $42,735,624.00 |
| State Street Corp | 31 Mar, 2026 | 1,716,823 | -520 | -0.03% | $54,079,925.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 1,660,696 | 5,440 | 0.33% | $52,311,924.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 1,600,000 | 100,000 | 6.67% | $50,400,000.00 |
| Bellevue Group AG | 31 Mar, 2026 | 1,528,518 | 0 | 0.00% | $48,148,317.00 |